Piperacillin 4gm + Tazobactam 0.5gm
| Composition | Piperacillin 4gm + Tazobactam 0.5gm |
|---|---|
| Packing | Vial+Wfi (Tray Pack) |
| MRP | ₹ 447 |
| Dosage Form | Injections |
Tazobz-4.5gm Injection is a broad-spectrum antibiotic injection containing Piperacillin 4 gm and Tazobactam 0.5 gm. Piperacillin is a powerful penicillin-type antibiotic, and Tazobactam is a beta-lactamase inhibitor that protects Piperacillin from being broken down by resistant bacteria — making this combination effective against a wide range of serious infections.
Used in hospital settings, Tazobz-4.5gm by Biozia Lifesciences is a trusted option for treating severe bacterial infections of the lungs, abdomen, skin, urinary tract, and other sites, especially when infections are caused by bacteria that may be resistant to other antibiotics.
This medicine is commonly used for:
Indicated for the treatment of moderate to severe bacterial infections caused by susceptible organisms, including: lower respiratory tract infections (including hospital-acquired and ventilator-associated pneumonia), complicated intra-abdominal infections, complicated urinary tract infections, skin and skin-structure infections (including diabetic foot infections), gynaecological infections, bacteraemia/septicaemia associated with these infections, and empirical therapy in febrile neutropenia. Effective against Gram-positive, Gram-negative, and anaerobic organisms, including many beta-lactamase-producing strains.
Tazobz-4.5gm works in two complementary ways. Piperacillin attacks and weakens the outer wall of bacteria, causing them to break open and die. Tazobactam acts as a shield — it blocks the enzymes (beta-lactamases) that some bacteria produce to destroy penicillin-type antibiotics. Together, they defeat a much wider range of dangerous bacteria than either could alone.
Piperacillin is an extended-spectrum ureidopenicillin that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), specifically PBP-1a, PBP-1b, and PBP-3, disrupting peptidoglycan cross-linking and causing cell lysis. Tazobactam is an irreversible inhibitor of class A and some class C beta-lactamases (including TEM, SHV, and certain AmpC variants), preventing enzymatic hydrolysis of piperacillin and restoring its activity against beta-lactamase-producing organisms such as Klebsiella pneumoniae, Escherichia coli, Bacteroides spp., and Staphylococcus aureus (non-MRSA).
The Piperacillin-Tazobactam combination is so effective against hospital-acquired infections that it is included in the WHO's list of Essential Medicines and is one of the most commonly used antibiotics in intensive care units worldwide.
Tazobz-4.5gm Injection is given by intravenous infusion under the supervision of a doctor or qualified nurse in a hospital or clinical setting. The dose and duration of treatment are determined by the type and severity of the infection and must be followed exactly as prescribed by your doctor.
Always follow the dosage and schedule advised by your doctor — this is general guidance only.
Common side effects may include diarrhoea, nausea, skin rash, headache, and pain or inflammation at the infusion site. Serious but rare effects include severe allergic reactions or Clostridioides difficile-associated diarrhoea. Tell your doctor if any side effect is severe or persistent.
Stronger antibiotics like Piperacillin-Tazobactam should be used first for any infection.
Broad-spectrum antibiotics like Piperacillin-Tazobactam are reserved for serious or resistant infections. Using them unnecessarily can contribute to antibiotic resistance.
If you start feeling better, you can stop the antibiotic early.
Stopping early allows surviving bacteria to multiply and can lead to treatment failure or resistance. Always complete the full course your doctor prescribes.